Park J, Choi W, Seong D, Jeong S, Lee J, Park H
Elife. 2024; 13.
PMID: 39717902
PMC: 11668528.
DOI: 10.7554/eLife.99833.
Ose N, Campitelli P, Modi T, Kazan I, Kumar S, Ozkan S
Elife. 2024; 12.
PMID: 38713502
PMC: 11076047.
DOI: 10.7554/eLife.92063.
Mohebbi F, Zelikovsky A, Mangul S, Chowell G, Skums P
Nat Commun. 2024; 15(1):2838.
PMID: 38565543
PMC: 10987511.
DOI: 10.1038/s41467-024-47304-6.
Shum M, Lee Y, Tam L, Xia H, Chung O, Guo Z
Comput Struct Biotechnol J. 2024; 23:759-770.
PMID: 38304547
PMC: 10831124.
DOI: 10.1016/j.csbj.2024.01.009.
Abutbul A, Mumblat H, Porat Y, Friedman N, Atari N, Sharabi S
Front Microbiol. 2023; 14:1296558.
PMID: 38094629
PMC: 10716356.
DOI: 10.3389/fmicb.2023.1296558.
Surveillance of SARS-CoV-2 Genetic Variants in the Polish Armed Forces Using Whole Genome Sequencing Analysis.
Skuza K, Rutyna P, Krzowski L, Rabalski L, Lepionka T
Int J Mol Sci. 2023; 24(19).
PMID: 37834302
PMC: 10573488.
DOI: 10.3390/ijms241914851.
Massive-scale genomic analysis reveals SARS-CoV-2 mutation characteristics and evolutionary trends.
Sun Y, Wang M, Lin W, Dong W, Xu J
mLife. 2023; 1(3):311-322.
PMID: 37732331
PMC: 9538474.
DOI: 10.1002/mlf2.12040.
Interface-Based Design of High-Affinity Affibody Ligands for the Purification of RBD from Spike Proteins.
Song S, Shi Q
Molecules. 2023; 28(17).
PMID: 37687186
PMC: 10489752.
DOI: 10.3390/molecules28176358.
Molecular epidemiological characteristics of SARS-CoV-2 in imported cases from 2021 to 2022 in Zhejiang Province, China.
Zhou B, Sun Y, Mao H, Su L, Lou Y, Yan H
Front Public Health. 2023; 11:1189969.
PMID: 37427288
PMC: 10323361.
DOI: 10.3389/fpubh.2023.1189969.
Evolution of Sequence and Structure of SARS-CoV-2 Spike Protein: A Dynamic Perspective.
Sinha A, Sangeet S, Roy S
ACS Omega. 2023; 8(26):23283-23304.
PMID: 37426203
PMC: 10324094.
DOI: 10.1021/acsomega.3c00944.
Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor.
Mahalingam G, Arjunan P, Periyasami Y, Dhyani A, Devaraju N, Rajendiran V
Sci Rep. 2023; 13(1):8743.
PMID: 37253762
PMC: 10227802.
DOI: 10.1038/s41598-023-35070-2.
The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD-ACE2 complex.
Peka M, Balatsky V
Future Virol. 2023; .
PMID: 37064325
PMC: 10089296.
DOI: 10.2217/fvl-2022-0152.
The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis.
Pascall D, Vink E, Blacow R, Bulteel N, Campbell A, Campbell R
PLoS One. 2023; 18(4):e0284187.
PMID: 37053201
PMC: 10101505.
DOI: 10.1371/journal.pone.0284187.
An update on SARS-CoV-2 immunization and future directions.
Rana R, Kant R, Kumra T, Gupta S, Rana D, Ganguly N
Front Pharmacol. 2023; 14:1125305.
PMID: 36969857
PMC: 10033701.
DOI: 10.3389/fphar.2023.1125305.
Molecular recognition of SARS-CoV-2 spike protein with three essential partners: exploring possible immune escape mechanisms of viral mutants.
Cheng Y, Zheng D, Zhang D, Guo D, Wang Y, Liu W
J Mol Model. 2023; 29(4):109.
PMID: 36964244
PMC: 10038388.
DOI: 10.1007/s00894-023-05509-4.
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity.
Ridgway H, Ntallis C, Chasapis C, Kelaidonis K, Matsoukas M, Plotas P
Viruses. 2023; 15(2).
PMID: 36851526
PMC: 9963001.
DOI: 10.3390/v15020309.
Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic.
Gonzalez-Vazquez L, Arenas M
Genes (Basel). 2023; 14(2).
PMID: 36833334
PMC: 9956206.
DOI: 10.3390/genes14020407.
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines.
Bayani F, Hashkavaei N, Arjmand S, Rezaei S, Uskokovic V, Alijanianzadeh M
Prog Biophys Mol Biol. 2023; 178:32-49.
PMID: 36801471
PMC: 9938630.
DOI: 10.1016/j.pbiomolbio.2023.02.004.
Revealing the Molecular Interactions between Human ACE2 and the Receptor Binding Domain of the SARS-CoV-2 Wild-Type, Alpha and Delta Variants.
Hognon C, Bignon E, Monari A, Marazzi M, Garcia-Iriepa C
Int J Mol Sci. 2023; 24(3).
PMID: 36768842
PMC: 9916449.
DOI: 10.3390/ijms24032517.
Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India.
Singh P, Sharma K, Shaw D, Bhargava A, Negi S
Front Med (Lausanne). 2023; 9:1082846.
PMID: 36755883
PMC: 9899822.
DOI: 10.3389/fmed.2022.1082846.